Global Veterinary Medicine

Veterinary Medicine Comprehensive Study by Type (Pharmaceuticals, Vaccines, Others), Application (Companion Animals, Farm Animals), Distribution Channel (Online, Offline), End User (Veterinary Clinics, Veterinary Hospitals, Research Institutions, Others) Players and Region - Global Market Outlook to 2028

Veterinary Medicine Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Veterinary Medicine
Veterinary medicine in treating as any drug used to treat a wide range of medical diseases in domestic animals. Veterinary medicine, for example, includes medications such as anti-infective treatments and parasiticides that are administered orally to animals to treat a variety of ailments. Vaccines are also used in veterinary medicine to immunise animals against a variety of viral diseases. They also include medicated feed additives, which are mixed with animal feed to provide medicinal effects to the animals receiving the feed.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The market for Veterinary medicine is highly competitive with several global as well as local players in the market. The global players are trying various strategies such as product innovation and using various marketing strategies to gain a higher market share. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Veterinary Medicine market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Zoetis, Inc. (United States), Mindray Medical International Limited (China), Smiths Group plc (United Kingdom), Nonin Medical (United States), Digicare Biomedical (United States), DRE Veterinary (United States), Midmark Corporation (United States), Jorgensen Laboratories (United States), Grady Medical Systems (United States), MILA International (United States), Burtons Medical (United Kingdom), Merck & Co., Inc. (United States), Eli Lilly and Company (United States), Bayer Healthcare AG (Germany) and Ceva Santé Animale (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Virbac S.A (France), Vetoquinol SA (France), Boehringer Ingelheim GmbH (Germany), Nutreco N.V.(Netherlands) and Sanofi S.A. (France).

Segmentation Overview
AMA Research has segmented the market of Global Veterinary Medicine market by Type (Pharmaceuticals, Vaccines and Others), Application (Companion Animals and Farm Animals) and Region.



On the basis of geography, the market of Veterinary Medicine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Veterinary Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Veterinary Clinics will boost the Veterinary Medicine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Advancement In Medical Technology And Increasing Research And Development Activities

Market Growth Drivers:
Growing Number Of Vets In Developing Countries and Growing Demand For Animal Welfare

Challenges:
Lack Of Infrastructure And Funding And Use Of Counterfeit Medicines

Restraints:
Lack Of Skilled Veterinarians

Opportunities:
Increasing Investment For Healthcare Infrastructure and Rising Awareness Towards Animal Health

On 24 April 2021 Hester Biosciences announced that on the occasion of World Veterinary Day, the company has launched a new range of Herbal Products for livestock and poultry in its existing range of products to support the overall wellbeing of animals, and to supplement our existing product range
On 28 January 2022, the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) becomes applicable. It contains new measures for stimulating innovation and increasing the availability and access to safe and high-quality veterinary medicines for veterinarians, farmers and pet owners to treat and prevent animal diseases and also supports the European Union (EU) action against antimicrobial resistance (AMR).

Key Target Audience
New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Pharmaceuticals
  • Vaccines
  • Others
By Application
  • Companion Animals
  • Farm Animals
By Distribution Channel
  • Online
  • Offline

By End User
  • Veterinary Clinics
  • Veterinary Hospitals
  • Research Institutions
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number Of Vets In Developing Countries
      • 3.2.2. Growing Demand For Animal Welfare
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Infrastructure And Funding And Use Of Counterfeit Medicines
    • 3.4. Market Trends
      • 3.4.1. Advancement In Medical Technology And Increasing Research And Development Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Veterinary Medicine, by Type, Application, Distribution Channel, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Veterinary Medicine (Value)
      • 5.2.1. Global Veterinary Medicine by: Type (Value)
        • 5.2.1.1. Pharmaceuticals
        • 5.2.1.2. Vaccines
        • 5.2.1.3. Others
      • 5.2.2. Global Veterinary Medicine by: Application (Value)
        • 5.2.2.1. Companion Animals
        • 5.2.2.2. Farm Animals
      • 5.2.3. Global Veterinary Medicine by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Veterinary Medicine by: End User (Value)
        • 5.2.4.1. Veterinary Clinics
        • 5.2.4.2. Veterinary Hospitals
        • 5.2.4.3. Research Institutions
        • 5.2.4.4. Others
      • 5.2.5. Global Veterinary Medicine Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Veterinary Medicine (Price)
      • 5.3.1. Global Veterinary Medicine by: Type (Price)
  • 6. Veterinary Medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Mindray Medical International Limited (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Smiths Group plc (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Nonin Medical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Digicare Biomedical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. DRE Veterinary (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Midmark Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Jorgensen Laboratories (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Grady Medical Systems (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. MILA International (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Burtons Medical (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Merck & Co., Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Eli Lilly and Company (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Bayer Healthcare AG (Germany)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Ceva Santé Animale (France)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Veterinary Medicine Sale, by Type, Application, Distribution Channel, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Veterinary Medicine (Value)
      • 7.2.1. Global Veterinary Medicine by: Type (Value)
        • 7.2.1.1. Pharmaceuticals
        • 7.2.1.2. Vaccines
        • 7.2.1.3. Others
      • 7.2.2. Global Veterinary Medicine by: Application (Value)
        • 7.2.2.1. Companion Animals
        • 7.2.2.2. Farm Animals
      • 7.2.3. Global Veterinary Medicine by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Veterinary Medicine by: End User (Value)
        • 7.2.4.1. Veterinary Clinics
        • 7.2.4.2. Veterinary Hospitals
        • 7.2.4.3. Research Institutions
        • 7.2.4.4. Others
      • 7.2.5. Global Veterinary Medicine Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Veterinary Medicine (Price)
      • 7.3.1. Global Veterinary Medicine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Veterinary Medicine: by Type(USD Million)
  • Table 2. Veterinary Medicine Pharmaceuticals , by Region USD Million (2017-2022)
  • Table 3. Veterinary Medicine Vaccines , by Region USD Million (2017-2022)
  • Table 4. Veterinary Medicine Others , by Region USD Million (2017-2022)
  • Table 5. Veterinary Medicine: by Application(USD Million)
  • Table 6. Veterinary Medicine Companion Animals , by Region USD Million (2017-2022)
  • Table 7. Veterinary Medicine Farm Animals , by Region USD Million (2017-2022)
  • Table 8. Veterinary Medicine: by Distribution Channel(USD Million)
  • Table 9. Veterinary Medicine Online , by Region USD Million (2017-2022)
  • Table 10. Veterinary Medicine Offline , by Region USD Million (2017-2022)
  • Table 11. Veterinary Medicine: by End User(USD Million)
  • Table 12. Veterinary Medicine Veterinary Clinics , by Region USD Million (2017-2022)
  • Table 13. Veterinary Medicine Veterinary Hospitals , by Region USD Million (2017-2022)
  • Table 14. Veterinary Medicine Research Institutions , by Region USD Million (2017-2022)
  • Table 15. Veterinary Medicine Others , by Region USD Million (2017-2022)
  • Table 16. South America Veterinary Medicine, by Country USD Million (2017-2022)
  • Table 17. South America Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 18. South America Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 19. South America Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 20. South America Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 21. Brazil Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 22. Brazil Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 23. Brazil Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 24. Brazil Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 25. Argentina Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 26. Argentina Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 27. Argentina Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 28. Argentina Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 29. Rest of South America Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 30. Rest of South America Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 31. Rest of South America Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 32. Rest of South America Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 33. Asia Pacific Veterinary Medicine, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 36. Asia Pacific Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 37. Asia Pacific Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 38. China Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 39. China Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 40. China Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 41. China Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 42. Japan Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 43. Japan Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 44. Japan Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 45. Japan Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 46. India Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 47. India Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 48. India Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 49. India Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 50. South Korea Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 51. South Korea Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 52. South Korea Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 53. South Korea Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 54. Taiwan Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 55. Taiwan Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 56. Taiwan Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 57. Taiwan Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 58. Australia Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 59. Australia Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 60. Australia Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 61. Australia Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 66. Europe Veterinary Medicine, by Country USD Million (2017-2022)
  • Table 67. Europe Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 68. Europe Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 69. Europe Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 70. Europe Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 71. Germany Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 72. Germany Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 73. Germany Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 74. Germany Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 75. France Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 76. France Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 77. France Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 78. France Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 79. Italy Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 80. Italy Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 81. Italy Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 82. Italy Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 83. United Kingdom Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 84. United Kingdom Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 85. United Kingdom Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 86. United Kingdom Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 87. Netherlands Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 88. Netherlands Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 89. Netherlands Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 90. Netherlands Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 91. Rest of Europe Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 92. Rest of Europe Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 93. Rest of Europe Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 94. Rest of Europe Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 95. MEA Veterinary Medicine, by Country USD Million (2017-2022)
  • Table 96. MEA Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 97. MEA Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 98. MEA Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 99. MEA Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 100. Middle East Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 101. Middle East Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 102. Middle East Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 103. Middle East Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 104. Africa Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 105. Africa Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 106. Africa Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 107. Africa Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 108. North America Veterinary Medicine, by Country USD Million (2017-2022)
  • Table 109. North America Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 110. North America Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 111. North America Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 112. North America Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 113. United States Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 114. United States Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 115. United States Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 116. United States Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 117. Canada Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 118. Canada Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 119. Canada Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 120. Canada Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 121. Mexico Veterinary Medicine, by Type USD Million (2017-2022)
  • Table 122. Mexico Veterinary Medicine, by Application USD Million (2017-2022)
  • Table 123. Mexico Veterinary Medicine, by Distribution Channel USD Million (2017-2022)
  • Table 124. Mexico Veterinary Medicine, by End User USD Million (2017-2022)
  • Table 125. Veterinary Medicine: by Type(USD/Units)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Veterinary Medicine: by Type(USD Million)
  • Table 142. Veterinary Medicine Pharmaceuticals , by Region USD Million (2023-2028)
  • Table 143. Veterinary Medicine Vaccines , by Region USD Million (2023-2028)
  • Table 144. Veterinary Medicine Others , by Region USD Million (2023-2028)
  • Table 145. Veterinary Medicine: by Application(USD Million)
  • Table 146. Veterinary Medicine Companion Animals , by Region USD Million (2023-2028)
  • Table 147. Veterinary Medicine Farm Animals , by Region USD Million (2023-2028)
  • Table 148. Veterinary Medicine: by Distribution Channel(USD Million)
  • Table 149. Veterinary Medicine Online , by Region USD Million (2023-2028)
  • Table 150. Veterinary Medicine Offline , by Region USD Million (2023-2028)
  • Table 151. Veterinary Medicine: by End User(USD Million)
  • Table 152. Veterinary Medicine Veterinary Clinics , by Region USD Million (2023-2028)
  • Table 153. Veterinary Medicine Veterinary Hospitals , by Region USD Million (2023-2028)
  • Table 154. Veterinary Medicine Research Institutions , by Region USD Million (2023-2028)
  • Table 155. Veterinary Medicine Others , by Region USD Million (2023-2028)
  • Table 156. South America Veterinary Medicine, by Country USD Million (2023-2028)
  • Table 157. South America Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 158. South America Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 159. South America Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 160. South America Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 161. Brazil Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 162. Brazil Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 163. Brazil Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 164. Brazil Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 165. Argentina Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 166. Argentina Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 167. Argentina Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 168. Argentina Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 169. Rest of South America Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 170. Rest of South America Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 171. Rest of South America Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 172. Rest of South America Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 173. Asia Pacific Veterinary Medicine, by Country USD Million (2023-2028)
  • Table 174. Asia Pacific Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 175. Asia Pacific Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 176. Asia Pacific Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 177. Asia Pacific Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 178. China Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 179. China Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 180. China Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 181. China Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 182. Japan Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 183. Japan Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 184. Japan Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 185. Japan Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 186. India Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 187. India Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 188. India Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 189. India Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 190. South Korea Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 191. South Korea Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 192. South Korea Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 193. South Korea Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 194. Taiwan Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 195. Taiwan Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 196. Taiwan Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 197. Taiwan Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 198. Australia Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 199. Australia Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 200. Australia Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 201. Australia Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 202. Rest of Asia-Pacific Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 203. Rest of Asia-Pacific Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 204. Rest of Asia-Pacific Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 205. Rest of Asia-Pacific Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 206. Europe Veterinary Medicine, by Country USD Million (2023-2028)
  • Table 207. Europe Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 208. Europe Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 209. Europe Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 210. Europe Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 211. Germany Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 212. Germany Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 213. Germany Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 214. Germany Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 215. France Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 216. France Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 217. France Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 218. France Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 219. Italy Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 220. Italy Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 221. Italy Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 222. Italy Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 223. United Kingdom Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 224. United Kingdom Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 225. United Kingdom Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 226. United Kingdom Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 227. Netherlands Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 228. Netherlands Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 229. Netherlands Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 230. Netherlands Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 231. Rest of Europe Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 232. Rest of Europe Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 233. Rest of Europe Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 234. Rest of Europe Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 235. MEA Veterinary Medicine, by Country USD Million (2023-2028)
  • Table 236. MEA Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 237. MEA Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 238. MEA Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 239. MEA Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 240. Middle East Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 241. Middle East Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 242. Middle East Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 243. Middle East Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 244. Africa Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 245. Africa Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 246. Africa Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 247. Africa Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 248. North America Veterinary Medicine, by Country USD Million (2023-2028)
  • Table 249. North America Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 250. North America Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 251. North America Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 252. North America Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 253. United States Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 254. United States Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 255. United States Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 256. United States Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 257. Canada Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 258. Canada Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 259. Canada Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 260. Canada Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 261. Mexico Veterinary Medicine, by Type USD Million (2023-2028)
  • Table 262. Mexico Veterinary Medicine, by Application USD Million (2023-2028)
  • Table 263. Mexico Veterinary Medicine, by Distribution Channel USD Million (2023-2028)
  • Table 264. Mexico Veterinary Medicine, by End User USD Million (2023-2028)
  • Table 265. Veterinary Medicine: by Type(USD/Units)
  • Table 266. Research Programs/Design for This Report
  • Table 267. Key Data Information from Secondary Sources
  • Table 268. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Veterinary Medicine: by Type USD Million (2017-2022)
  • Figure 5. Global Veterinary Medicine: by Application USD Million (2017-2022)
  • Figure 6. Global Veterinary Medicine: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global Veterinary Medicine: by End User USD Million (2017-2022)
  • Figure 8. South America Veterinary Medicine Share (%), by Country
  • Figure 9. Asia Pacific Veterinary Medicine Share (%), by Country
  • Figure 10. Europe Veterinary Medicine Share (%), by Country
  • Figure 11. MEA Veterinary Medicine Share (%), by Country
  • Figure 12. North America Veterinary Medicine Share (%), by Country
  • Figure 13. Global Veterinary Medicine: by Type USD/Units (2017-2022)
  • Figure 14. Global Veterinary Medicine share by Players 2022 (%)
  • Figure 15. Global Veterinary Medicine share by Players (Top 3) 2022(%)
  • Figure 16. Global Veterinary Medicine share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Zoetis, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Zoetis, Inc. (United States) Revenue: by Geography 2022
  • Figure 20. Mindray Medical International Limited (China) Revenue, Net Income and Gross profit
  • Figure 21. Mindray Medical International Limited (China) Revenue: by Geography 2022
  • Figure 22. Smiths Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. Smiths Group plc (United Kingdom) Revenue: by Geography 2022
  • Figure 24. Nonin Medical (United States) Revenue, Net Income and Gross profit
  • Figure 25. Nonin Medical (United States) Revenue: by Geography 2022
  • Figure 26. Digicare Biomedical (United States) Revenue, Net Income and Gross profit
  • Figure 27. Digicare Biomedical (United States) Revenue: by Geography 2022
  • Figure 28. DRE Veterinary (United States) Revenue, Net Income and Gross profit
  • Figure 29. DRE Veterinary (United States) Revenue: by Geography 2022
  • Figure 30. Midmark Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Midmark Corporation (United States) Revenue: by Geography 2022
  • Figure 32. Jorgensen Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 33. Jorgensen Laboratories (United States) Revenue: by Geography 2022
  • Figure 34. Grady Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 35. Grady Medical Systems (United States) Revenue: by Geography 2022
  • Figure 36. MILA International (United States) Revenue, Net Income and Gross profit
  • Figure 37. MILA International (United States) Revenue: by Geography 2022
  • Figure 38. Burtons Medical (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 39. Burtons Medical (United Kingdom) Revenue: by Geography 2022
  • Figure 40. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Merck & Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 42. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 43. Eli Lilly and Company (United States) Revenue: by Geography 2022
  • Figure 44. Bayer Healthcare AG (Germany) Revenue, Net Income and Gross profit
  • Figure 45. Bayer Healthcare AG (Germany) Revenue: by Geography 2022
  • Figure 46. Ceva Santé Animale (France) Revenue, Net Income and Gross profit
  • Figure 47. Ceva Santé Animale (France) Revenue: by Geography 2022
  • Figure 48. Global Veterinary Medicine: by Type USD Million (2023-2028)
  • Figure 49. Global Veterinary Medicine: by Application USD Million (2023-2028)
  • Figure 50. Global Veterinary Medicine: by Distribution Channel USD Million (2023-2028)
  • Figure 51. Global Veterinary Medicine: by End User USD Million (2023-2028)
  • Figure 52. South America Veterinary Medicine Share (%), by Country
  • Figure 53. Asia Pacific Veterinary Medicine Share (%), by Country
  • Figure 54. Europe Veterinary Medicine Share (%), by Country
  • Figure 55. MEA Veterinary Medicine Share (%), by Country
  • Figure 56. North America Veterinary Medicine Share (%), by Country
  • Figure 57. Global Veterinary Medicine: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Zoetis, Inc. (United States)
  • Mindray Medical International Limited (China)
  • Smiths Group plc (United Kingdom)
  • Nonin Medical (United States)
  • Digicare Biomedical (United States)
  • DRE Veterinary (United States)
  • Midmark Corporation (United States)
  • Jorgensen Laboratories (United States)
  • Grady Medical Systems (United States)
  • MILA International (United States)
  • Burtons Medical (United Kingdom)
  • Merck & Co., Inc. (United States)
  • Eli Lilly and Company (United States)
  • Bayer Healthcare AG (Germany)
  • Ceva Santé Animale (France)
Additional players considered in the study are as follows:
Virbac S.A (France) , Vetoquinol SA (France) , Boehringer Ingelheim GmbH (Germany) , Nutreco N.V.(Netherlands) , Sanofi S.A. (France)
Select User Access Type

Key Highlights of Report


Jun 2023 226 Pages 89 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Veterinary Medicine Quantitative research analysis
Global Veterinary Medicine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Zoetis, Inc. (United States), Mindray Medical International Limited (China), Smiths Group plc (United Kingdom), Nonin Medical (United States), Digicare Biomedical (United States), DRE Veterinary (United States), Midmark Corporation (United States), Jorgensen Laboratories (United States), Grady Medical Systems (United States), MILA International (United States), Burtons Medical (United Kingdom), Merck & Co., Inc. (United States), Eli Lilly and Company (United States), Bayer Healthcare AG (Germany) and Ceva Santé Animale (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Advancement In Medical Technology And Increasing Research And Development Activities" is seen as one of major influencing trends for Veterinary Medicine Market during projected period 2022-2028.
The Veterinary Medicine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Veterinary Medicine Report?

Have a Query? Click Here

Other Related Reports

Tretinoin Drugs Comprehensive Study by Type (Oral, Injection), Application (Keratinization Disorders, Acute Promyelocytic Leukemia (APL), Others), End-users (Hospitals, Clinics, Others), Distribution...
$ 3350
Patent Medicine Comprehensive Study by Type (Product Patents, Process Patents), Application (Adult, Children), Drug Type (Solid Drug, Semi-Solid Drug, Liquid Drug, Gas/Aerosol Drug, Others), Disease ...
$ 3750
Over The Counter (OTC) Drugs Comprehensive Study by Type (Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalm...
$ 3750
Intravenous (IV) Ibuprofen Comprehensive Study by Application (Pediatrics, Adults), Indication (Pain/Inflammatory, Fever), Form (Tablet, Capsule, Suspension, Other) Players and Region - Global Market...
$ 3500
Anticholinergic Drugs Comprehensive Study by Type (Synthetic Compounds, Natural, Semi-Synthetic Compounds), Application (Overactive Bladder, Parkinson’s Disease, Chronic Obstructive Pulmonary Disease...
$ 3650
Candesartan Comprehensive Study by Application (Hypertension, Cardiovascular Risks, Chronic Kidney Diseases), Doses (4 mg, 8 mg, 16 mg, 32 mg), Distribution Channel (Hospital Pharmacies, Retail Pharm...
$ 3450